Gene · 5216
Papers2,319
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,319
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects. | Int J Mol Sci | 2023 | 37298466 | PubTator, text mining | PubMed |
| Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy. | Front Neurosci | 2023 | 37250416 | PubTator, text mining | PubMed |
| Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel. | Discov Oncol | 2023 | 37243787 | PubTator, text mining | PubMed |
| lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma. | Genes (Basel) | 2023 | 37239411 | PubTator, text mining | PubMed |
| Cyclic processes in the uterine tubes, endometrium, myometrium, and cervix: pathways and perturbations. | Mol Hum Reprod | 2023 | 37225518 | PubTator, text mining | PubMed |
| 18 F-FDG Brain PET/MRI in Amyotrophic Lateral Sclerosis- Frontotemporal Spectrum Disorder (ALS-FTSD). | World J Nucl Med | 2023 | 37223625 | PubTator, text mining | PubMed |
| iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions. | J Clin Invest | 2023 | 37219933 | PubTator, text mining | PubMed |
| Determination of optimum intensity and duration of exercise based on the immune system response using a machine-learning model. | Sci Rep | 2023 | 37217586 | PubTator, text mining | PubMed |
| Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers. | Front Immunol | 2023 | 37205098 | PubTator, text mining | PubMed |
| Celloscope: a probabilistic model for marker-gene-driven cell type deconvolution in spatial transcriptomics data. | Genome Biol | 2023 | 37198601 | PubTator, text mining | PubMed |
| Role of Oxidative Stress on the Etiology and Pathophysiology of Amyotrophic Lateral Sclerosis (ALS) and Its Relation with the Enteric Nervous System. | Curr Issues Mol Biol | 2023 | 37185741 | PubTator, text mining | PubMed |
| Paget's disease: a review of the epidemiology, etiology, genetics, and treatment. | Front Genet | 2023 | 37180975 | PubTator, text mining | PubMed |
| Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls. | J Transl Med | 2023 | 37179299 | PubTator, text mining | PubMed |
| Profilin1 Regulates Trophoblast Invasion and Macrophage Differentiation. | Am J Pathol | 2023 | 37164274 | PubTator, text mining | PubMed |
| A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity. | Cell Rep | 2023 | 37155329 | PubTator, text mining | PubMed |
| DNA Methylation Analysis in Monozygotic Twins Discordant for ALS in Blood Cells. | Epigenet Insights | 2023 | 37152709 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients. | Front Oncol | 2023 | 37152048 | PubTator, text mining | PubMed |
| ALS-causing hPFN1 mutants differentially disrupt LLPS of FUS prion-like domain. | Biochem Biophys Res Commun | 2023 | 37130459 | PubTator, text mining | PubMed |
| In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders. | Front Mol Neurosci | 2023 | 37122628 | PubTator, text mining | PubMed |
| Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery. | Pharmaceutics | 2023 | 37111603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5216/papers?page=13